HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Terbium-161

Also Known As:

161Tb radioisotope; Tb-161 radioisotope

Networked: 5 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Inorganic Chemicals: 9

Experts

1.	Köster, Ulli: 3 articles (01/2022 - 10/2014)
2.	Müller, Cristina: 3 articles (01/2022 - 08/2019)
3.	Schibli, Roger: 3 articles (01/2022 - 10/2014)
4.	Zeevaart, Jan Rijn: 3 articles (01/2022 - 08/2019)
5.	van der Meulen, Nicholas P: 3 articles (01/2022 - 08/2019)
6.	Bernhardt, Peter: 2 articles (04/2021 - 08/2019)
7.	Borgna, Francesca: 1 article (01/2022)
8.	Ginj, Mihaela: 1 article (01/2022)
9.	Grundler, Pascal V: 1 article (01/2022)
10.	Haller, Stephanie: 1 article (01/2022)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2022 - "The β¯-emitting terbium-161 also emits conversion and Auger electrons, which are believed to be effective in killing single cancer cells. " 01/01/2022 - "Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms." 08/01/2023 - "Terbium-161 (161Tb) has been recently investigated as a potential radionuclide for radiotheranostics in various types of cancer, including metastatic castration-resistant prostate cancer (mCRPC). "
2.	Ovarian Neoplasms (Ovarian Cancer) 10/01/2014 - "Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model."
3.	Prostatic Neoplasms (Prostate Cancer) 08/01/2019 - "Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer." 08/01/2023 - "Terbium-161 (161Tb) has been recently investigated as a potential radionuclide for radiotheranostics in various types of cancer, including metastatic castration-resistant prostate cancer (mCRPC). "
4.	Neoplasm Metastasis (Metastasis) 04/22/2021 - "In conclusion, the simulations demonstrated that terbium-161 has the potential for being a more effective targeted radionuclide therapy for metastases using PSMA ligands."

Related Drugs and Biologics

1.	Lutetium-177
2.	Radioisotopes (Radionuclides)
3.	Somatostatin Receptors (Somatostatin Receptor)
4.	Ligands

Related Therapies and Procedures

1.	Radioimmunotherapy
2.	Therapeutics
3.	Castration